A prescription for improved chronic disease management: Have community pharmacists function at the top of their training

Archives of Internal Medicine

Volumn 170, Issue 18, 2010, Pages 1646-1647

  Guglielmo, B Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULATION; BLOOD PRESSURE MEASUREMENT; CHRONIC DISEASE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; MEDICATION ERROR; NOTE; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; SMOKING CESSATION;

BLOOD PRESSURE MONITORING, AMBULATORY; CHRONIC DISEASE; COUNSELING; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; PHARMACIES; PHARMACISTS; PHYSICIANS; PROFESSIONAL ROLE; SMOKING CESSATION;

EID: 77957942145     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.343     Document Type: Note

References (8)

1. Grumbach K. Redesign of the health care delivery system: a Bauhaus "form follows function" approach. JAMA. 2009;302(21):2363-2364.
2. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001;21(2):129-141. (Pubitemid 32120146)
3. Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy. 2004;24(8):953-963.
4. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481-493. (Pubitemid 46536228)
5. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267-270.
6. Weber CA, Ernst ME, Sezate GS, Zheng S, Carter BL. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170(18):1634-1639.
7. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003). 2008;48(2):203-211.
8. Cranor CW, Bunting BA, Christensen DB. The Ashville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43(2):173-184.